Melatonin Activates KEAP1/NRF2/PTGS2 Pathway to Attenuate Hyperoxia-Driven Ferroptosis in Bronchopulmonary Dysplasia
Xianhui Deng,1,2,* Anni Xie,2,* Danni Ye,2 Yizhe Ma,1 Zhidan Bao,1 Qiuyan Xie,2 Zichen Luo,2 Ran Wang,2 Hu Li,1 Renqiang Yu2 1Department of Neonatology, Jiangyin People’s Hospital, Wuxi, People’s Republic of China; 2Department of Neonatology, Affiliated Women’s Hospital of Ji...
Saved in:
Main Authors: | Deng X, Xie A, Ye D, Ma Y, Bao Z, Xie Q, Luo Z, Wang R, Li H, Yu R |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2025-06-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/melatonin-activates-keap1nrf2ptgs2-pathway-to-attenuate-hyperoxia-driv-peer-reviewed-fulltext-article-JIR |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anthrahydroquinone-2,6-Disulfonate Restores Lung Function in COPD Through Keap1/Nrf2 Pathway Activation
by: Li Z, et al.
Published: (2025-07-01) -
Modulation of the KEAP1-NRF2 pathway by Erianin: A novel approach to reduce psoriasiform inflammation and inflammatory signaling
by: Yan Hongmei, et al.
Published: (2025-07-01) -
Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2
by: N. P. Denisenko, et al.
Published: (2022-02-01) -
Design, Synthesis, and Evaluation of Nitroxide Radical Derivatives Based on Rhein as Potential Anti-Aging Agents Targeting the Keap1-Nrf2 Pathway
by: Wang J, et al.
Published: (2025-06-01) -
The Keap1/Nrf2/ARE system activators do not increase cardiac resistance to long-term ischemia/reperfusion
by: P. M. Kozhin, et al.
Published: (2022-12-01)